Literature DB >> 8950988

T-cell lymphomas in v-Myb transgenic mice.

P A Badiani1, D Kioussis, D M Swirsky, I A Lampert, K Weston.   

Abstract

v-Myb, the transforming protein of avian myeloblastosis virus, causes acute myeloid leukemia in chickens. Similarly, truncation and rearrangement of the c-myb proto-oncogene to yield a v-Myb-like protein leads to myeloid and B cell lymphomas in chickens and mice, and may be a factor in a number of human cancers. To study the effects of deregulation of v-Myb on T cell development, we have generated lines of transgenic mice in which the v-Myb oncoprotein is expressed in a T-cell-specific fashion. Analysis of T cell development in the v-Myb transgenic mice shows that ectopic expression of v-Myb affects the ratio of helper to cytotoxic T cells, by increasing the number of CD4+ helper cells, and inhibits thymic involution, such that mature animals have elevated numbers of thymocytes and circulating mature T cells. In a significant proportion of older animals, high grade T cell lymphomas develop, demonstrating that v-Myb is oncogenic in T cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8950988

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

1.  c-Myb regulates lineage choice in developing thymocytes via its target gene Gata3.

Authors:  Diane Maurice; Joel Hooper; Georgina Lang; Kathleen Weston
Journal:  EMBO J       Date:  2007-07-19       Impact factor: 11.598

2.  The human neuroendocrine thyrotropin-releasing hormone receptor promoter is activated by the haematopoietic transcription factor c-Myb.

Authors:  Vilborg Matre; Per I Høvring; Ase-Karine Fjeldheim; Lars Helgeland; Christophe Orvain; Kristin B Andersson; Kaare M Gautvik; Odd S Gabrielsen
Journal:  Biochem J       Date:  2003-06-15       Impact factor: 3.857

3.  MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia.

Authors:  E Mets; J Van der Meulen; G Van Peer; M Boice; P Mestdagh; I Van de Walle; T Lammens; S Goossens; B De Moerloose; Y Benoit; N Van Roy; E Clappier; B Poppe; J Vandesompele; H-G Wendel; T Taghon; P Rondou; J Soulier; P Van Vlierberghe; F Speleman
Journal:  Leukemia       Date:  2014-09-18       Impact factor: 11.528

4.  Positive and negative regulation of c-Myb by cyclin D1, cyclin-dependent kinases, and p27 Kip1.

Authors:  Wanli Lei; Fan Liu; Scott A Ness
Journal:  Blood       Date:  2005-02-01       Impact factor: 22.113

5.  c-Myb transcription is activated by protein kinase B (PKB) following interleukin 2 stimulation of Tcells and is required for PKB-mediated protection from apoptosis.

Authors:  A Lauder; A Castellanos; K Weston
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

6.  Beta-catenin stabilization stalls the transition from double-positive to single-positive stage and predisposes thymocytes to malignant transformation.

Authors:  Zhuyan Guo; Marei Dose; Damian Kovalovsky; Rui Chang; Jennifer O'Neil; A Thomas Look; Harald von Boehmer; Khashayarsha Khazaie; Fotini Gounari
Journal:  Blood       Date:  2007-02-22       Impact factor: 22.113

7.  Overexpression of an alternatively spliced form of c-Myb results in increases in transactivation and transforms avian myelomonoblasts.

Authors:  C H Woo; L Sopchak; J S Lipsick
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

8.  Alternative RNA splicing produces multiple forms of c-Myb with unique transcriptional activities.

Authors:  John P O'Rourke; Scott A Ness
Journal:  Mol Cell Biol       Date:  2008-01-14       Impact factor: 4.272

9.  Genome-based identification of cancer genes by proviral tagging in mouse retrovirus-induced T-cell lymphomas.

Authors:  Rachel Kim; Alla Trubetskoy; Takeshi Suzuki; Nancy A Jenkins; Neal G Copeland; Jack Lenz
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

10.  A novel model of SCID-X1 reconstitution reveals predisposition to retrovirus-induced lymphoma but no evidence of gammaC gene oncogenicity.

Authors:  Linda Scobie; Ralph D Hector; Louise Grant; Margaret Bell; Anne A Nielsen; Sharon Meikle; Adrian Philbey; Adrain Philbey; Adrian J Thrasher; Adrain J Thrasher; Ewan R Cameron; Karen Blyth; James C Neil
Journal:  Mol Ther       Date:  2009-03-31       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.